O
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Price:
11 910
KRW
15.63%
Market Closed
Market Cap:
₩210.2B
Balance Sheet
Balance Sheet Decomposition
Optus Pharmaceutical Co Ltd
Optus Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Optus Pharmaceutical Co Ltd
Optus Pharmaceutical Co Ltd
Balance Sheet
Optus Pharmaceutical Co Ltd
Optus Pharmaceutical Co Ltd
Currency: KRW
| Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
84
|
2 219
|
442
|
24 186
|
27 118
|
28 245
|
42 008
|
54 447
|
33 876
|
35 157
|
42 422
|
2 005
|
4
|
17 811
|
26 906
|
|
| Cash |
0
|
0
|
2
|
1
|
4
|
2
|
4
|
1
|
5
|
4
|
5
|
5
|
4
|
14 811
|
20 906
|
|
| Cash Equivalents |
84
|
2 219
|
440
|
24 185
|
27 114
|
28 243
|
42 004
|
54 446
|
33 871
|
35 153
|
42 417
|
2 000
|
0
|
3 000
|
6 000
|
|
| Short-Term Investments |
29 199
|
27 776
|
0
|
0
|
1 444
|
3 002
|
1 000
|
0
|
25 293
|
34 000
|
34 973
|
37 000
|
51 146
|
40 000
|
24 502
|
|
| Total Receivables |
91
|
91
|
4 959
|
5 035
|
7 760
|
6 308
|
9 057
|
7 567
|
6 474
|
13 656
|
4 108
|
6 564
|
7 908
|
9 995
|
13 753
|
|
| Accounts Receivables |
91
|
91
|
4 956
|
5 004
|
7 072
|
6 289
|
9 006
|
7 531
|
6 430
|
7 598
|
4 082
|
6 527
|
7 878
|
9 936
|
13 658
|
|
| Other Receivables |
0
|
0
|
3
|
31
|
688
|
19
|
51
|
36
|
44
|
6 058
|
26
|
37
|
30
|
59
|
95
|
|
| Inventory |
0
|
0
|
2 467
|
2 756
|
3 452
|
3 903
|
4 063
|
4 640
|
4 985
|
5 820
|
6 748
|
9 791
|
11 622
|
13 071
|
12 500
|
|
| Other Current Assets |
1
|
4
|
116
|
232
|
42
|
27
|
123
|
101
|
48
|
26
|
5 179
|
5 106
|
302
|
10 895
|
235
|
|
| Total Current Assets |
29 375
|
30 090
|
7 984
|
32 209
|
39 817
|
41 486
|
56 251
|
66 756
|
70 676
|
88 659
|
93 431
|
91 017
|
81 386
|
91 772
|
77 896
|
|
| PP&E Net |
0
|
0
|
21 765
|
20 998
|
23 777
|
28 303
|
27 157
|
25 382
|
22 913
|
24 138
|
28 267
|
38 717
|
43 735
|
42 501
|
56 863
|
|
| Intangible Assets |
0
|
0
|
109
|
270
|
323
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16 066
|
|
| Note Receivable |
0
|
0
|
100
|
66
|
0
|
0
|
0
|
0
|
6 000
|
0
|
0
|
0
|
35
|
44
|
10
|
|
| Long-Term Investments |
0
|
0
|
160
|
0
|
3 005
|
2 982
|
0
|
1 883
|
3 829
|
5 706
|
8 124
|
9 633
|
10 121
|
13 497
|
13 740
|
|
| Other Long-Term Assets |
0
|
0
|
132
|
330
|
472
|
369
|
441
|
550
|
487
|
465
|
75
|
671
|
964
|
1 647
|
1 928
|
|
| Total Assets |
29 375
N/A
|
30 090
+2%
|
30 250
+1%
|
53 874
+78%
|
67 394
+25%
|
73 140
+9%
|
83 848
+15%
|
94 571
+13%
|
103 905
+10%
|
118 969
+14%
|
129 897
+9%
|
140 038
+8%
|
136 240
-3%
|
149 460
+10%
|
166 503
+11%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
0
|
0
|
2 045
|
1 180
|
2 642
|
1 538
|
1 283
|
1 523
|
760
|
1 118
|
1 213
|
1 519
|
1 536
|
1 889
|
3 124
|
|
| Accrued Liabilities |
0
|
0
|
1 074
|
1 652
|
2 531
|
2 735
|
3 663
|
4 270
|
4 742
|
5 935
|
3 908
|
4 885
|
5 804
|
7 976
|
5 638
|
|
| Short-Term Debt |
0
|
0
|
6 585
|
0
|
1 000
|
2 000
|
2 000
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
5 753
|
4 342
|
1 700
|
0
|
0
|
0
|
0
|
102
|
108
|
73
|
680
|
713
|
695
|
|
| Other Current Liabilities |
0
|
1
|
613
|
175
|
2 582
|
712
|
789
|
1 245
|
2 209
|
2 560
|
3 353
|
4 897
|
1 739
|
2 493
|
11 653
|
|
| Total Current Liabilities |
1
|
1
|
16 070
|
7 349
|
10 456
|
6 986
|
7 735
|
7 038
|
7 712
|
9 715
|
8 582
|
11 375
|
9 760
|
13 072
|
21 110
|
|
| Long-Term Debt |
1 657
|
1 746
|
6 441
|
1 374
|
0
|
0
|
0
|
0
|
0
|
73
|
352
|
167
|
1 918
|
1 359
|
759
|
|
| Deferred Income Tax |
54
|
76
|
198
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
828
|
0
|
15
|
494
|
738
|
|
| Other Liabilities |
0
|
0
|
51
|
237
|
448
|
669
|
858
|
979
|
1 293
|
1 434
|
1 251
|
1 475
|
80
|
84
|
162
|
|
| Total Liabilities |
1 711
N/A
|
1 823
+7%
|
22 760
+1 148%
|
8 960
-61%
|
10 904
+22%
|
7 654
-30%
|
8 593
+12%
|
8 017
-7%
|
9 004
+12%
|
11 222
+25%
|
11 014
-2%
|
13 018
+18%
|
11 773
-10%
|
15 009
+27%
|
22 768
+52%
|
|
| Equity | ||||||||||||||||
| Common Stock |
3 625
|
3 625
|
1 348
|
7 592
|
8 162
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
8 282
|
|
| Retained Earnings |
102
|
502
|
2 510
|
3 737
|
13 031
|
21 603
|
31 358
|
42 773
|
51 051
|
63 887
|
77 034
|
85 281
|
86 636
|
95 689
|
103 978
|
|
| Additional Paid In Capital |
24 140
|
24 140
|
1 924
|
32 316
|
36 341
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
36 663
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
4
|
14
|
0
|
117
|
47
|
38
|
29
|
137
|
762
|
404
|
136
|
|
| Treasury Stock |
0
|
0
|
0
|
1 048
|
1 048
|
1 048
|
1 048
|
1 048
|
1 048
|
1 048
|
3 068
|
3 068
|
6 352
|
0
|
0
|
|
| Other Equity |
0
|
0
|
1 707
|
2 316
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5 779
|
5 052
|
|
| Total Equity |
27 663
N/A
|
28 267
+2%
|
7 490
-74%
|
44 914
+500%
|
56 490
+26%
|
65 486
+16%
|
75 256
+15%
|
86 554
+15%
|
94 901
+10%
|
107 747
+14%
|
118 883
+10%
|
127 021
+7%
|
124 467
-2%
|
134 451
+8%
|
143 735
+7%
|
|
| Total Liabilities & Equity |
29 375
N/A
|
30 090
+2%
|
30 250
+1%
|
53 874
+78%
|
67 394
+25%
|
73 140
+9%
|
83 848
+15%
|
94 571
+13%
|
103 905
+10%
|
118 969
+14%
|
129 897
+9%
|
140 038
+8%
|
136 240
-3%
|
149 460
+10%
|
166 503
+11%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
7
|
7
|
3
|
15
|
16
|
16
|
16
|
16
|
16
|
16
|
16
|
16
|
15
|
15
|
15
|
|
Switch to:
Switch to:
See Also
Discover More
